Health and productivity benefits of anti-PD-(L)1 agents for early-stage cancer treatment in Hungary
{{output}}
Aim: Anti-PD-(L)1 agents, inhibitors of programmed cell death protein 1 (PD-1) or its ligand (PD-L1), are established therapies that improve cancer management as well as the disease and societal burden of specific metastatic and ... ...
